Z-1520-2018 Class III Terminated
FDA device recall Z-1520-2018 was initiated by Diagnostic Hybrids, Inc. on Oct 26, 2016 and is designated Class III. Reason for recall: There may be a loss of separation between Calibrators A and B which may impact the assay calibration at the lower end of the assay. The recall status is terminated (terminated Aug 28, 2020). Affected quantity: 26.
Recall details
- Product Type
- Devices
- Report Date
- May 2, 2018
- Initiation Date
- Oct 26, 2016
- Termination Date
- Aug 28, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 26
Product description
Quidel MicroVue Intact PTH EIA, Model 8044. An enzyme immunoassay for the quantification of Intact Parathyroid Hormone (PTH) in serum.
Reason for recall
There may be a loss of separation between Calibrators A and B which may impact the assay calibration at the lower end of the assay.
Distribution pattern
The product was distributed to the following countries: Singapore, Switzerland
Code information
Lot 068259
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1520-2018
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026